San Francisco Sentry Investment Group CA continued to hold its stake in shares of Colgate-Palmolive Co. (NYSE:CL) during the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 18,499 shares of the company’s stock at the end of the third quarter. San Francisco Sentry Investment Group CA’s holdings in Colgate-Palmolive were worth $1,372,000 at the end of the most recent quarter.
Several other large investors have also recently made changes to their positions in the company. Quadrant Capital Group LLC raised its stake in shares of Colgate-Palmolive by 200.6% in the third quarter. Quadrant Capital Group LLC now owns 1,485 shares of the company’s stock worth $103,000 after buying an additional 991 shares in the last quarter. Krilogy Financial LLC raised its stake in shares of Colgate-Palmolive by 3.2% in the second quarter. Krilogy Financial LLC now owns 1,504 shares of the company’s stock worth $110,000 after buying an additional 46 shares in the last quarter. Concannon Wealth Management LLC raised its stake in shares of Colgate-Palmolive by 33.8% in the third quarter. Concannon Wealth Management LLC now owns 1,605 shares of the company’s stock worth $119,000 after buying an additional 405 shares in the last quarter. Tompkins Financial Corp raised its stake in shares of Colgate-Palmolive by 121.1% in the second quarter. Tompkins Financial Corp now owns 1,698 shares of the company’s stock worth $124,000 after buying an additional 930 shares in the last quarter. Finally, Arcadia Investment Management Corp MI raised its stake in shares of Colgate-Palmolive by 28.6% in the second quarter. Arcadia Investment Management Corp MI now owns 1,800 shares of the company’s stock worth $132,000 after buying an additional 400 shares in the last quarter. Institutional investors and hedge funds own 73.12% of the company’s stock.
Shares of Colgate-Palmolive Co. (NYSE:CL) opened at 66.53 on Friday. The stock has a 50 day moving average of $69.86 and a 200-day moving average of $72.23. The firm has a market capitalization of $59.13 billion, a P/E ratio of 43.51 and a beta of 0.73. Colgate-Palmolive Co. has a 12-month low of $61.40 and a 12-month high of $75.38.
Colgate-Palmolive (NYSE:CL) last released its quarterly earnings results on Thursday, October 27th. The company reported $0.73 earnings per share for the quarter, hitting the Thomson Reuters’ consensus estimate of $0.73. The company had revenue of $3.87 billion for the quarter, compared to analysts’ expectations of $3.94 billion. Colgate-Palmolive had a return on equity of 6,924.14% and a net margin of 8.96%. The business’s quarterly revenue was down 3.3% compared to the same quarter last year. During the same period in the previous year, the business posted $0.80 earnings per share. On average, equities research analysts predict that Colgate-Palmolive Co. will post $2.82 EPS for the current fiscal year.
The company also recently declared a quarterly dividend, which was paid on Tuesday, November 15th. Stockholders of record on Monday, October 24th were issued a dividend of $0.39 per share. This represents a $1.56 annualized dividend and a dividend yield of 2.34%. The ex-dividend date of this dividend was Thursday, October 20th. Colgate-Palmolive’s dividend payout ratio (DPR) is currently 101.96%.
Several research analysts have recently issued reports on CL shares. Zacks Investment Research raised shares of Colgate-Palmolive from a “hold” rating to a “buy” rating and set a $83.00 target price on the stock in a research note on Monday, October 3rd. Exane BNP Paribas lowered shares of Colgate-Palmolive from an “outperform” rating to a “neutral” rating in a research note on Friday, July 29th. JPMorgan Chase & Co. reaffirmed a “hold” rating and issued a $75.00 target price on shares of Colgate-Palmolive in a research note on Friday, July 29th. B. Riley reaffirmed a “neutral” rating and issued a $78.00 target price (up previously from $71.00) on shares of Colgate-Palmolive in a research note on Friday, October 28th. Finally, Wells Fargo & Co. reaffirmed a “market perform” rating on shares of Colgate-Palmolive in a research note on Tuesday, November 15th. Twelve research analysts have rated the stock with a hold rating and five have issued a buy rating to the company. The stock presently has a consensus rating of “Hold” and an average price target of $76.04.
In other news, insider Patricia Verduin sold 3,834 shares of the business’s stock in a transaction dated Monday, October 17th. The stock was sold at an average price of $72.39, for a total transaction of $277,543.26. Following the sale, the insider now directly owns 55,013 shares in the company, valued at $3,982,391.07. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. Insiders own 1.05% of the company’s stock.
Colgate-Palmolive Company Profile
Colgate-Palmolive Company (Colgate) is a consumer products company, whose products are marketed in over 200 countries and territories throughout the world. The Company’s segments include Oral, Personal and Home Care, and Pet Nutrition. The Oral, Personal and Home Care product segment is operated through over five geographic segments, which include North America, Latin America, Europe/South Pacific, Asia and Africa/Eurasia.